1. Home
  2. VIVS vs ASTI Comparison

VIVS vs ASTI Comparison

Compare VIVS & ASTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIVS
  • ASTI
  • Stock Information
  • Founded
  • VIVS 2007
  • ASTI 2005
  • Country
  • VIVS United States
  • ASTI United States
  • Employees
  • VIVS N/A
  • ASTI N/A
  • Industry
  • VIVS Biotechnology: Biological Products (No Diagnostic Substances)
  • ASTI Semiconductors
  • Sector
  • VIVS Health Care
  • ASTI Technology
  • Exchange
  • VIVS Nasdaq
  • ASTI Nasdaq
  • Market Cap
  • VIVS 3.6M
  • ASTI 2.9M
  • IPO Year
  • VIVS N/A
  • ASTI N/A
  • Fundamental
  • Price
  • VIVS $1.84
  • ASTI $1.62
  • Analyst Decision
  • VIVS
  • ASTI
  • Analyst Count
  • VIVS 0
  • ASTI 0
  • Target Price
  • VIVS N/A
  • ASTI N/A
  • AVG Volume (30 Days)
  • VIVS 71.5K
  • ASTI 40.2K
  • Earning Date
  • VIVS 06-13-2025
  • ASTI 08-05-2025
  • Dividend Yield
  • VIVS N/A
  • ASTI N/A
  • EPS Growth
  • VIVS N/A
  • ASTI N/A
  • EPS
  • VIVS N/A
  • ASTI N/A
  • Revenue
  • VIVS $144,000.00
  • ASTI $51,917.00
  • Revenue This Year
  • VIVS $59.08
  • ASTI N/A
  • Revenue Next Year
  • VIVS $18.24
  • ASTI N/A
  • P/E Ratio
  • VIVS N/A
  • ASTI N/A
  • Revenue Growth
  • VIVS N/A
  • ASTI N/A
  • 52 Week Low
  • VIVS $1.56
  • ASTI $1.17
  • 52 Week High
  • VIVS $21.96
  • ASTI $14.18
  • Technical
  • Relative Strength Index (RSI)
  • VIVS N/A
  • ASTI 46.50
  • Support Level
  • VIVS N/A
  • ASTI $1.54
  • Resistance Level
  • VIVS N/A
  • ASTI $1.77
  • Average True Range (ATR)
  • VIVS 0.00
  • ASTI 0.11
  • MACD
  • VIVS 0.00
  • ASTI -0.01
  • Stochastic Oscillator
  • VIVS 0.00
  • ASTI 22.86

About VIVS VivoSim Labs Inc. Common Stock

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.

Share on Social Networks: